Subsequent copy number studies, with larger DIPG patient tumor cohorts, revealed frequently altered genes (Table 1) including PDGFRA, TP53, PARP1, PVT-1/MYC, RB1, and PTEN (3, 38, 39). This evidence concerns the gene TP53 and neoplasm.